Given a paragraph and a claim, classify it this way: If the claim contradicts the evidence present in the paragraph, classify the claim as '0'. If the claim has multiple supporting *AND* contradicting evidences, classify the claim as '1'. If the claim has supporting evidence and the paragraph is in overall favor of the claim, then classify the claim as '2'.

Let me give you an example: Paragraph: While the financial costs of screening mammography&!1-positive recalls&biopsies were not included in the study,readers would benefit from being reminded that recall mammography&biopsies increase patient financial costs.This article leads with valuable information for all women over age 40 by stating "Getting screening mammograms every two years instead of annually reduces the chance of a!1 alarm,a new study shows." Unfortunately the writer doesn't quantify or elaborate adequately on that reduction.Instead,the writer later focuses on how women undergoing screening mammography shouldn't be anxious if they experience a recall because over half of women who have screening mammograms for 10 years will be recalled.Readers would have been better served if the writer had emphasized the significant reduction in both recall mammograms&!1-positive biopsies in women who are screened every two years rather than annually.Part of the continuing controversy over screening mammography focuses on annual versus biennial screening.Because this study showed a significant reduction in the percentage of those recalled&needing biopsies among women who are screened every other year,with no statistically significant increase in late-stage diagnosis of breast cancer,the article should have emphasized those important findings.The piece states that the researchers noted that "!1 positive recalls may cause inconvenience&anxiety and biopsies can cause pain and scarring." This article fails to include several important facts about the study.1)This is a prospective cohort study of women screened between 1994-2006.2)Most of the mammograms were film rather than digital.3)Few women underwent screening for the entire 10 year period.4)Screening mammography recall rates are influenced by the skill of the radiologists who read the mammograms.There was no disease mongering.No independent experts were quoted.The story did an adequate job comparing at a very high level annual screening versus biennial screening.Screening mammography is widely available throughout the United States.The study did not examine a new procedure.There's no evidence that the story relied solely on a news release.
Claim: Annual Mammograms May Have More False-Positives
The answer to this example can be: 1
Here is why: This article reports on the results of a study of nearly 170,0 women who had screening mammograms beginning between age 40-59.The study found that over ten years of screening mammograms,over half of the women will experience a!1-positive recall for additional mammography.In addition,7%-9%of the women will have a biopsy for a suspicious lump which is not cancerous.Both of those percentages decrease if the woman is screened every other year rather than every year.Even with biennial mammography,41%of women will experience a recall over 10 years of mammography.The study's Principal Investigator emphasized that "in most cases,a recall doesn't mean you have cancer." She hoped this knowledge would reduce the anxiety of women who are recalled.The story never explained the size of the decrease in the number of!1 positives between annual(61.3%) and biennial screening(41.6%).Our first two reviewers were a researcher who specializes in health decisions and a breast cancer survivor trained in evidence by the Natiional Breast Cancer Coalition's Project LEAD.This study is valuable because it helps to quantify and compare the harms of annual and biennial screening,specifically the number of!1 positives and the number of unnecessary biopsies.Prior to this study,estimates of!1 positive screening mammography rates varied widely.The critical question is whether you can do less frequent screening,subject women to fewer harms and get similar results in terms of detection of "early stage" cancer.This study's data seems to suggest that answer is yes.

OK. solve this:
Paragraph: "The story provides the cost of the machine but does not mention how this would influence the treatment costs for the patient. We are not told if this method of cancer treatment would be covered by health insurance, or how the cost would compare to current radiation treatments. The story does not provide any quantification of benefit. The story is a promotional vehicle for a new, potentially cost-prohibitive machine manufactured by TomoTherapy. We are told that proton therapy will work better for patients than radiation, but no data are given to show that this is the case. The story notes potential harms of radiation, but mentions no harms of proton therapy. Proton therapy is not without side effects; this story inappropriately minimizes potential harm of proton beam. Clearly, future clinical studies will help define better the harms, but the story should have noted potential for harms. Common harms include hair loss, skin rash, fatigue story says ""patient won't have undue side effects"" whatever 'undue side effects' may mean the harms are not inconsequential for sure. Here's what another proton center lists: What are some of the side effects from proton therapy?Side effects will depend on the patient's age, medical history, diagnosis, disease size and location. Some patients may receive chemotherapy in conjunction with proton therapy; some will receive much lower radiation doses than others and therefore symptoms will vary significantly. Common symptoms include temporary hair loss and skin reactions in the direct path of the radiation. Fatigue is also associated treatment to large areas. The story provides no quantitative evidence that the proton therapy is better than current radiation. Despite company reassurances, we do not know if this form of therapy is as efficacious as current radiation or if it is safe. We are also not told if this therapy is only for a particular type of cancer or if it could be used on tumors anywhere in the body. The story does not engage in disease mongering, but promotes a new technology and potential future option for cancer treatment. The story cites Dr. DeVere White and Dr. Matthew of UC Davis Cancer. Researchers at this center helped finance research and development of the proton therapy machines with TomoTherapy, Inc., so they have an interest in positively promoting their work. The story also cites a senior project manager at TomoTherapy, Inc., who also cannot provide unbiased information about this new device. The story needs balance from cancer researchers (esp. radiation oncologists) and clinicians to provide perspective on this emerging technology as cancer treatment. The story presents proton therapy as a newer, alternative option for shrinking tumors; however, this technology as cancer therapy is still in early development, thought it has received FDA approval for cancer treatment. The story gives us no data to support this newer option as better than existing methods of X-ray radiation treatment for cancer. There have been advances in standard radiation therapy with the goal of minimizing harm to healthy tissue, and the story does not mention that current forms of X-ray radiation can be targeted to a tumor via computer imaging and the use of devices (i.e. balloon, seeds, etc.) Mary, unsure here if we need to mention the latter, but thought it was important as they position this as proton therapy v. harmful radiation. Radiation, at least as much as I know for breast cancer, is now safer. The story mentions that the proton therapy machines are only in five cancer centers in the U.S.. Space and cost are provided as the reason this therapy is not widely available, but cancer centers may be waiting for evidence that this therapy is safe and works as well (or better) than current forms of targeted radiation delivery. The story presents a new technologyproton therapyas an option for shrinking tumors; however, the story gives us no data to support this newer option as better than existing methods of X-ray radiation treatment for cancer. We can't be sure if the story relied soley or largely on a press release, but there is very little new information in the story that is NOT in a news release posted by TomoTherapy, Inc., makers of the proton therapy machine promoted in the news story." Claim: Partnership plans to build cancer treatment machine
Answer:
1